Lateral flow immunoassay devices, systems and methods for detecting hemoglobinopathies, including α-thalassemia 1 trait Southeast Asian (SEA) type, are provided. Point-of-care devices and methods for screening subjects for the presence of hemoglobin Z in blood samples are provided. Methods of screening patients for α-thalassemia using low cost, simple point-of-care devices are provided.
展开▼